Search papers, labs, and topics across Lattice.
This paper introduces DIASENTINEL, a multi-agent system designed for one-year type 2 diabetes mellitus risk screening that leverages electronic health records to generate guideline-grounded reports. By integrating calibrated risk prediction, deterministic clinical signal extraction, and a hybrid verification layer, the system addresses the vulnerabilities of large language models, such as hallucinations and unsupported recommendations. The results showcase a reliable, auditable, and privacy-preserving framework that enhances clinical decision support in diabetes care.
A fully auditable AI system can transform diabetes risk screening by ensuring guideline adherence and mitigating the risks of LLM hallucinations.
Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with LLM entailment. The demonstration provides a real-time batch-screening dashboard and an interactive patient report interface with cited recommendations, verification results, and raw EHR comparison. DIASENTINEL demonstrates a practical framework for reliable, auditable, and privacy-preserving LLM-based clinical decision support.
